During the past decade, NZOZ Reumed conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Reumed" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "4SC AG" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Arana Therapeutics Ltd" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Reumed" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Reumed" are "Rheumatoid Arthritis" (7 trials), "Arthritis, Rheumatoid" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials) and "Scleroderma, Diffuse" (1 trials). Many other conditions were trialed in "NZOZ Reumed" in a lesser frequency.

Most popular intervention types in "NZOZ Reumed" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (2 trials), "Methotrexate" (2 trials), "Tocilizumab" (2 trials) and "peficitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Reumed" are 13 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Reumed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in NZOZ Reumed, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Reumed, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".